Medical doctors at the
Indian Council of Medical Research have completed a clinical trial for a new
male birth control that will involve syringe shots directly into the penis.
This new medical
product according to the Hindustan Times, could prevent men from getting women
pregnant and could last for 13 years- and all it needed was permission from the
Indian government before it enters the market.
The procedure called
the reversible inhibition of sperm under guidance or RISUG is a painful and
invasive one which involves a polymer being delivered via injection into the
semen-producing glad, vas deferens, which is located on the penis near the
testicles. It is an alternative to
surgical vasectomy.
Dr RS Sharma, senior
scientist with ICMR, who has been spearheading the trials said “The product is
ready, with only regulatory approvals pending with the Drugs Controller. The
trials are over, including extended, phase 3 clinical trials for which 303
candidates were recruited with 97.3% success rate and no reported side-effects.
The product can safely be called the world’s first male contraceptive,” .
“It’s the first in the
world from India so we have to be extra careful about approval. We are looking
at all aspects, especially the good manufacturing practice (GMP) certification
that won’t raise any questions about its quality,” said VG Somani, the drug
controller general of India.
